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The sera of patients  with rheumatoid arthritis  frequently contain  elevated 
concentrations  of gamma globulins  that  have  sedimentation  coefficients,  on 
ultracentrifugation, of about 19 Svedberg units (19S) (1, 2). These macroglobu- 
lins,  collectively  known  as  "rheumatoid  factors,"  are  recognized  by  their 
ability to react with 7S gamma globulins under appropriate conditions in vitro 
(3-7).  Because  these  characteristics  suggest  immunologic  capabilities  it  has 
been postulated  that  these substances  are antibodies  to gamma globulin and 
that their presence signifies an "auto-immune" state (7-10). To date no direct 
evidence has been obtained to implicate the rheumatoid factors in the genesis 
of rheumatoid arthritis (10, 11).  Nevertheless, speculation continues regarding 
their origin and possible functions. 
The studies  herein  described were undertaken  in an attempt to determine 
whether  rheumatoid  rnacroglobulins  act  like  known  heterologous  antibodies 
to human gamma globulin and whether they function in vivo. To this end, their 
effects in vitro  and  in  vivo on red  cells sensitized with incomplete antibodies 
were observed and compared with those produced by immune antiglobulins. 1 
Materials and Methods 
I.  Studies in Rats: 
A. Immunization of Rats.--Fresh blood was obtained from the lateral ear veins of 2 white 
male albino rabbits and from the hearts of male Sprague-Dawley rats of a caesarian-derived, 
Bartondla-free strain.  2 The blood specimens were allowed to clot for 1 hour at 37°C, and the 
sera separated by centrifugafion and stored in 2 ml aliquots at --20°C until used. 
* This  investigation was supported in part by Grant GM-03507-11 from the  National 
Institutes  of Health, Bethesda. 
Postdoctoral Fellow, the National Heart Institute,  United States Public Health Service. 
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I A preliminary report of this work has previously been published (12). 
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The recipient animals were large (400 to 550 gin) males of the same strain as the donor 
rats. They were paired by weight and one of each pair received, by injection into the foot- 
pads and into multiple subcutaneous sites,  1.0 ml of rabbit serum thoroughly emulsified in 
1 ml of complete Freund's adjuvant? The paired control animals received, in an identical 
fashion, 1.0 ml of isologous rat serum in adjuvant. Weekly thereafter, for 6 weeks, 1.0 ml of 
the appropriate  serum without adjuvant was  administered intraperitoneally. The red  cell 
survival studies, to be described below, were performed within 2  to 4 weeks after the last 
serum injection. 
B. Sensitization  of Rat Red Cdls.--Rat red cells from isologous donors were labeled with 
Cr  514 and sensitized with non-agglutinating quantities of rabbit antirat red cell antiserum as 
previously described (13). The agglutinating and sensitizing characteristics of this antiserum 
are depicted in Table I. 
C. Red Cell Survival  Studies.--In  each experiment 4 animals were studied simultaneously, 
2 rats immunized with rabbit serum and 2 that had received rat serum. Before the survival 
TABLE  I 
The effect of Rabbit Anti-Rat Red Cell Serum (7-59) on Rat Red Cells in Vitro 
Rabbit antiserum, ral 
Rat red cells,  ml 
0.000 
0.020 
0.027 
0.050 
0.080 
0.133 
0.200 
Hemolysis 
in fresh rat serum 
0 
0 
0 
0 
0 
0 
0 
In serum 
0 
0 
0 
0 
1+ 
2 to 3+ 
3 to 4+ 
Agglutination 
In PVP.* 
0 
2 to3+ 
3+ 
3 to 4+ 
4+ 
4+ 
4+ 
* PVP, a buffered (pH 7.4)  solution of 5 per cent polyvinylpyrrolidone, K-44. 
studies were begun, 0.2 ml of whole blood was taken by tail puncture from each animal into 
capillary tubes. The blood was allowed to clot and the serum separated by centrifugation. 
The undiluted sera were tested for their ability to agglutinate a  5 per cent suspension of the 
sensitized red cells whose survival was to be studied. The sensitized cells were then injected, 
their survival and sites of sequestration determined, and the results calculated and expressed 
as de.~cribed in a  previous publication (14). At the time of sacrifice, 3 hours after injection, 
the animals were exsanguinated by cardiac puncture and the derived sera were collected. 
In two experiments a 50 per cent suspension of Cr~l-labeled rat cells sensitized with rabbit 
antiserum was secondarily incubated for 1 hour, with an equal volume of pooled, undiluted 
serum from rats that had been immunized with rabbit serum or that had been comparably 
injected with rat serum. After incubation, the degree of agglutination was determined and the 
survival and sequestration of these doubly incubated cells were measured in normal, non- 
immunized rats. 
s Dffco Laboratories, Detroit. 
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H.  Studies in Man: 
A. Materials.-- 
1.  Red cells. Whole blood was obtained as required from a  single normal donor of blood 
group O, R1Rz (CCDee) and mixed with 1/4 volume of sterile ACD.  s The red ceils were used 
within a few hours of the time the blood was drawn. 
2.  Incomplete  anti-Rh antisera.  Plasma from 3  hyperimmunized donors was used. Their 
individual serological characteristics and  reactivities with normal donor red ceils are illus- 
trated in Table II. 
3.  Rheumatoid  sera. Sera were obtained from 35 patients with rheumatoid  arthritis ex- 
hibiting strongly positive latex fixation tests  e and were stored at --20°C until used. 
4.  Rabbit  antiserum.  Rabbit antiserum against whole human  serum was prepared  by re- 
peatedly injecting a single albino rabbit with normal human serum according to the method 
of Emerson et al. (15). Prior to use the antiserum was heated for 30 minutes at 56°C and ab- 
TABLE H 
The Serological Characteristics in Vitro of Various Anti-Rk Antisera versus 
Type O, RIRx Red Cells 
Source of 
antiserum 
Hanl 
Ges 
Mur~ 
Specificity 
Anti-D 
Anti-CD 
Anti-CDE 
Saline agglutlnin 
titer 
0 
Tr 
!  1:2 
Indirect anti- 
globulin titer 
1:256 
1:512 
!  1:512 
Om (~)* type 
+ 
p 
-§ 
* We are grateful to Dr. Hugh Fudenberg for Gin-typing many of the sera employed. 
~; Anti-gh Murphy supplied by Knickerbocker Laboratories, New York. 
§ The Gm type of Mur serum was reported by Haxboe (34) to be Gm (a -- bq- x--). 
sorbed twice with 2 volumes of washed, packed human red ceils pooled from type A1, B, O, 
and AB donors. The resulting serum, which did not agglutinate normal human red ceils, was 
stored in 2.0 ml allquots at -20°C. As required, aliquots were thawed and sterilized by pas- 
sage through a Mililpore filter  ~ of pore size 0.45/z. 
5.  D#uent.  Unless stated otherwise, unbuffered 0.85 per cent saline was employed in all 
studies. 
B. Methods.-- 
1.  Sensitiza6on  of red cells with anti-Rk antisera.  Red ceils from the normal donor were 
washed twice in large volumes of saline and brought to a 50 per cent concentration in saline. 
To 1 volume of the 50 per cent red cell suspension was added either (a)  1 volume "Ham.", 
(b)  1/5 volume "Ges.", or (c) 1/5 volume "Mur." These amounts of the various sera were se- 
lected because they had been found in preliminary experiments to produce comparable rates 
and patterns of sequestration of Rh-positive red ceils in ~ivo. Following incubation for 1 hour 
5 ACD, acid citrate dextrose mixture, Abbott Laboratories, North Chicago. 
e The cooperation of Dr.  Ellis Dressner,  Dr.  Sumner Frank,  Dr. Alan Cohen,  and  Dr. 
Arthur Hall is gratefully acknowledged. 
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at 37°C, the cells were washed thrice and suspended in sufficient saline to provide a 5 per cent 
red cell concentration for in vitro studies or a  50 per cent red cell concentration for in vivo 
studies. 
g.  Agglutination  studies.  Two fold serial dilutions of the rheumatoid sera,  ranging from 
neat serum to  1:16,384, were prepared in 0.2 ml quantities. To each dilution was added an 
equal volume of a  given 5 per cent suspension of sensitized red cells.  After incubation for 2 
hours at room temperature the cells were resuspended by gently tapping the tubes and the 
intensity of red cell agglutination was observed macro- and microscopically. The degree of 
agglutination was categorized as follows: 1+  =  microscopic agglutination of 5 to 10 per cent 
of cells; 2+  =  microscopic agglutination of 20 to 35 per cent of cells; 3+  =  macroscopic 
agglutination involving more than 50 per cent, but less than 75 per cent, of the cells; 4+  = 
gross macroscopic clumping involving more than 75 per cent of all red cells.  Five of the 35 
rheumatoid sera were selected for further study because they induced unusually strong ag- 
glutination (more than "3+") of red cells coated with one or more of the antisera (Table 
m). 
3.  Absorption  studies.  To  a  volume of rheumatoid serum "Cor.,"  (a)  undiluted and  (b) 
diluted 1 : 50 in saline, were added 3 volumes of packed red cells sensitized with anti-Rh anti- 
serum Ges. As controls, unsensitized red cells were added in an identical fashion to neat and 
dilute rheumatoid serum Cor. Following incubation for 1 hour at room temperature, the cells 
were packed by centrifugation and the supernatant sera were removed. The latter were re- 
incubated with packed ceils as before and,  thereafter, the entire procedure repeated for a 
third time. The supernatants from the third incubation were titered for rheumatoid factor 
activity against a  5 per cent suspension of Ges.-sensitized red cells in the usual fashion. 
4.  Agglutination-inhibition  studies.  To each of four series of test tubes containing 0.05 ml 
of packed red ceils previously sensitized with Ges. was added 0.95 ml of either serially diluted 
human serum albumin  s  (the initial tube containing an albumin concentration of 5  gm per 
cent) or serially diluted serum from (a) a normal individual, (b) a hypergiobulinemic patient 
with multiple myeloma, and (c) a patient with acquired agammagiobulinemia. The cells were 
dispersed thoroughly in the suspending media, and 1.0 ml of a  1:64 dilution of rheumatoid 
serum Cor. was pipetted into each tube. Mter incubation for 2 hours at room temperature, 
each tube of the four series of tubes was examined for red cell agglutination. 
5.  Survival  studies  of sensitized  red cells. The destruction in vivo of Rh-sensitized red cells 
was studied in (a) a  group of 7 control subjects (for the most part elderly, male alcoholics 
without clinical evidence of liver disease), and  (b) in 5 patients with rheumatoid arthritis  9 
whose sera strongly agglutinated the sensitized red cell preparations employed. 25 ml of nor- 
mal blood was collected in sterile non-pyrogenic ACD and labeled with 150 to 250 #c. of Cr  61 
as previously described  (16). Thereafter, the cells were washed,  sensitized with one of the 
three anti-Rh antisera employed, and rewashed thoroughly (as described in section lib  (1)). 
The absence of red cell agglutination was confirmed microscopically before infusion of the 
cells into the recipient. The survival of these sensitized red cells was measured as in previous 
studies (17) utilizing external body scanning over the precordium, liver, and spleen to localize 
red cell sequestration. 
When so indicated, the CrSl-labded sensitized red cells were subjected to a second incuba- 
tion in vitro, either with sterile rheumatoid serum previously obtained from the subject under 
study or with sterile rabbit antiserum. In the first instance, a 50 per cent suspension in saline 
of sensitized Cr51-1abeled red cells that had been washed thrice in saline was added to equal 
8 Nutritional Biochemicals Corporation,  Cleveland. 
We are indebted to Dr. Mortimer S. Greenberg and Dr. Marvin L. Mitchell of the Lemuel 
Shattuck Hospital, Boston, for making several of these studies possible. t~ 
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volumes of rheumatoid serum (undiluted or diluted, as specified). After incubation for 1 hour 
at room temperature, the cells were thoroughly dispersed by repeated inversion of the con- 
tainer, examined for agglutination, and injected promptly into the recipient without prior 
washing. Incubation of sensitized red cells with the heterologous rabbit antiserum was per- 
formed in an identical fashion with the exception that 10 volumes of a 50 per cent suspension 
of unlabeled type O, Rh-negative (rr) red cells were added to the sensitized Cr~l-labeled cells 
prior to the addition of the rabbit antiserum; this step was taken to retard formation of large 
agglutinates that might cause untoward reactions. No such reactions were observed in any 
of the subjects studied. 
RESULTS 
I.  St~ies in Rats: 
When rat red cells lightly sensitized with rabbit antibody were suspended in 
normal rat serum or in the sera of rats that had been injected repeatedly with 
rat serum, no agglutination or hemolysis took place. Mter their injection into 
such "control" rats, these lightly sensitized cells were cleared relatively slowly 
from the circulation,  and were sequestered principally in the spleen (Fig.  1). 
In one instance the amount of antiserum employed was so small that the sub- 
sequent survival of the sensitized cells was essentially normal (Fig. 1 B). When 
rat red cells, similarly sensitized with rabbit antibody, were suspended in the 
sera of rats that had been immunized against rabbit serum, there was no hemol- 
ysis, but agglutination did occur, as expected.  Following their injection into 
such  rats these sensitized cells were cleared from the circulation much more 
rapidly and completely, and the main site of sequestration was the liver (Fig. 1). 
It is apparent that the degree and velocity of sensitized red cell destruction ob- 
served in an individual animal immunized with rabbit serum correlated well 
with the capacity of the animal's serum to agglutinate the injected cells. 
That the enhanced destruction of sensitized red ceils in rats immunized with 
rabbit serum is serologicMly determined was clearly demonstrated in a  subse- 
quent study. Prior to their injection, the sensitized rat red cells were incubated 
with pooled serum from rats immunized with rabbit serum. When this prepara- 
tion  was  infused  into  normal animals,  the kinetics  of red  cell sequestration 
mimicked that obsesrved following injection of sensitized red cells into actively 
immunized animals  (Fig.  2). 
H. Studies in Man: 
A. Rheumatoid Factors.- 
In vitro observations.  As indicated in Table III the agglutination by a  given 
rheumatoid serum of type O, R1R1 red cells sensitized with any of three Rh- 
antisera is characterized by (a) great variability in the resultant intensity of 
agglutination depending upon the source of coating azltibody and (b) prozones 
that are invariably present and extraordinarily broad.  The specificity of the 
reaction between rheumatoid factors and the anti-Rh coating antibodies has 
been attributed  to the existence of genetically determined differences among MANUEL  E. KAPLAN AND ~AMES H. ~'ANDL  111 
human  7S gamma globulins (18).  The latter, on the strength of this finding, 
have been subdivided into the so called "Gin-types." In the present studies the 
Gm  specific]ties of  the  reactive  components  were  identified only  in  certain 
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1  F,o. l. The survival and sites of sequestration in rats of Cr  5 -labeled rat red cells sensitized 
with rabbit antiserum. In Fig. 1 A the ratio of antiserum/packed cells was 0.050; in Fig. 1 B 
it was 0.027. The "immunized" rats (triangles) had been injected previously  with rabbit serum 
tt  ~t  and their sera contained anti-rabbit globulins  in variable amounts. The  control  rats (circles) 
had been injected in a comparable manner with homologous rat serum. The degree of agglu- 
tination of sensitized cells in each recipient's serum is represented by a figure in parentheses 
(0 to 4+) above the respective survival curve. 
instances. It was sufficient for our purposes to determine to what degree a given 
rheumatoid serum would agglutinate red cells coated with a specific antiserum. 
However, the nature of the prozone phenomenon was investigated more fully. 
It was found  that  a  prozone was  invariably present whenever a  rheumatoid 112  IMMUNE HEMOLYSIS IN VIVO 
serum interacted with sensitized red cells to produce agglutination, z° Despite 
the testing of rheumatoid sera from 35 separate patients  we were  unable  to 
find a single serum that, in the undiluted state strongly agglutinated  red  cells 
sensitized with any o5 the 4 Rh-antisera  studied. The prozones that developed 
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Fro. 2. The survival and sites of sequestration in normal rats of CrSLlabeled, antibody- 
treated red cells preincubated in ~itro with "control" rat serum or with rat serum containing 
antibodies against rabbit serum, Each point represents the mean of 2 observations. 
when Rh-sensitized  red  cells were incubated in rheumatoid sera differed sig- 
nificantly from those frequently observed with incubation of similarly sensitized 
red cells in heterologous antiglobulin (Coombs) serum. Thus, with rheumatoid 
sera prozones were invariable and marked and no correlation could be observed 
between the prozone range and the agglutination titer, whereas in the Coombs 
xo In addition to the  three anti-Rh  sara described in detail, a small supply of anti-Rh 
"Ripley" was generously suppfied to us by Dr. Ellis Dressner, and was utilized in similar 
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reaction, prozones occur irregularly, often weakly and usually appear when the 
antiglobulin concentration is very high and the quantity of cell-fixed  globulin 
is small; i.e., there is a marked antiglobulin excess (19). In several of the rheuma- 
toid sera studied, prozones were so marked that there were more tubes in the 
lower dilution range that lacked any agglutination than there were tubes show- 
ing agglutination. Furthermore, it was observed that the mere addition of saline 
to a  suspension of sensitized red cells in the prozone range produced prompt 
agglutination. Once agglutinated, the cells could be washed in saline repeatedly 
without disagglutinating. The simplest explanation for the prozone phenomenon 
observed here is that serum contains a factor or factors that either (a)  inhibit 
the interaction of rheumatoid factor with cell-fixed  antibody or (b)  stabilize 
TABLE  IV 
The Agglutination of Rh-Sensitir~t  Red Cells by Rheumatoid Serum--lnhlbition by 
Various Sera Containing Different Concentrathms of "r-Globulin 
Source of serum 
)final 
Agamma- 
globulinemic 
~pergamma- 
globulinemic 
~~-o% I  o 
gra per cent 
1.05  0 
0.025  1+ 
9.38  4+* 
0 
3+ 
1+* 
Dilution of inhibitory  sera 1: 
3to4+ 
I  0 
8  16 
2+  3 to 4+ 
4+  4+ 
0  0 
32  64  128 
4+  4+  4+ 
4+  4+,  4+ 
0  ±  2to3+ 
256 
4+ 
4+ 
3 to 4+ 
512  1024 2048 
4+  4+  4+ 
4+  4+  4+ 
4+  4+  4+ 
*  Agglutination in these  first  two tubes is attributable  to the non-specific  effect  of high concentrations  of 
rouleaux-inducing  globulins  (36). 
the product of this reaction. To investigate these possibilities the following 
experiments were performed: 
1.  Agglutination inhibition studies:  The addition of human serum albumin, 
in various concentrations up to 5 gm per cent, to a  system containing Ges.- 
sensitized red cells and dilute rheumatoid serum (Cor.  1:64) failed to inhibit 
red cell agglutination. When similar studies were performed, substituting for 
serum  albumin  human  sera  containing  different  quantities  of  "y-globulin, 
variable prozones resulted--the degree of inhibition produced by a given serum 
being directly proportional to its "y-globulin content (Table IV). 
2.  Absorption studies: Repeated incubations of rheumatoid sera with packed 
sensitized red cells  demonstrated that agglutinating activity was not specifi- 
cally absorbed from undiluted rheumatoid serum. On the other hand, signifi- 
cant absorption did occur in the dilute system, as evidenced by diminished 
intensity of red cell agglutination and a fall in absolute titer (Table V). 
In  ~ivo observations.  The  survival  of  Cra-labeled type O,  RxR1 red  cells 
sensitized in vitro with various Rh-antisera was measured in 7 control subjects 
and in the 5 patients with rheumatoid arthritis whose serum, when appropri- 114  W/MUNE  HEMOLYSIS  IN VIVO 
ately  diluted,  most  strongly  agglutinated  the  particular  sensitized  red  cell 
preparation to be infused.  Two control subjects and  2  rheumatoid  patients 
were studied on more than one occasion. Prior studies (17) have shown that in 
TABLE V 
Titration of Residual Rheumatoid Factor Aaidty after Absorption of Rheumatoid 
Serum with Packed Red Cells 
Dilution of 
rheumatoid 
serum 
absorbed 
0 
1:50 
Red 
cells 
SensL 
tiz~ 
Con- 
trol 
Sensi- 
tize 
Con- 
trol 
Dilution of absorbate 1: 
0  2  4  8  16  32  64  128  256  512  1024 
0  ±  t+  2+  3+  4+  4+  4+  4+  4+3to4+ 
0  0  t+  2+  s to4+  4+  4+  4+ I 4+  4+2to3+ 
3+  4+  4+3to4+  2+  1+  0  0  I 0  0  0 
4+  4+  4+  4+  [  4+  r  to4+  2+ t 1+[±  0  t  O 
204g,  92 16,384 
0 
0 
0 
0 
TABLE VI 
The Sequestratgon of Rh-Semitized Red Cells in Human Sub 
Subject 
Normal 
Bay.. 
O'Mal. 
Corz  ........ 
Murp 
Boy. 
Bronz.. 
Bail. 
Rheumatoid artkrit~ 
Mar.* 
Dick.. 
lug 
West.. 
Cor.(a) ..... 
Cot. (b). 
Cor. (c). 
Anti-Rh 
Gas. 
Ham. 
Mur. 
Ges. 
lc 
Ham. 
Mur. 
Cr~ survival 
,t ~, mln. 
32.0 
29.0 
19.5 
26.5 
17.0 
35.0 
22.0 
4.2 
17.0 
19.5 
27.5 
22.5 
23.0 
29.5 
~ects 
CPM 
Spleen/fiver 
3.0 
6.5 
3.9 
1.2 
5.4 
1.1 
3.6 
3.9 
4.1 
1.8 
3.1 
2.3 
1.7 
1.3 
* Patient  Mar. has marked splenomegaly  and clinical evidence of "hypersplenism." 
normal  individuals  the  usual  half-survival  time  of  such  sensitized  red  cells 
ranges from 17 to 35 minutes with splenic far exceeding hepatic sequestration. 
The results obtained in the present control group are in accord with the pre- 
vious findings (Table VI, Fig. 3). In 4 of the 5 patients with rheumatoid arth- MANUEL  E.  KAPLAN  AND  JAMES  H.  S'ANDL  115 
ritis studied,  the rates of disappearance and patterns of sequestration of the 
sensitized cells fell entirely within  the normal range  (Table V-I, Fig. 4).  The 
fifth patient (Mar.) cleared his circulation of sensitized  red cells with abnormal 
rapidity (t ~  =  4  to 5 minutes), with splenic sequestration predominating. 
However, this patient's clinical status differed from that of the other 4 in that 
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FIo. 3.  The survival in normal individuals of Cr51-1abeled red cells sensitized with various 
anti-Rh sera. 
it was complicated by splenomegaly and  leukopenia.  In order  to determine 
whether the alacrity with which sensitized red cells were sequestered by this 
patient  was attributable  to rheumatoid  factor activity or to an abnormally 
avid reticuloendothelial system, cells were injected that had been altered by a 
non-immunologic mechanism. For this purpose, normal CrSl-labeled cells that 
had been treated with 8 rn~ N-ethylmaleimide (NEM) (20) were injected; the 
half-survival of such cells in normal subjects is similar to that of Rh-sensitized 
cells, about 22 minutes (21). In patient Mar., however, their half-survival was 116  ttE~IOL¥SIS IN VIVO 
14 minutes. Consequently, we suspect that in this patient a hyperactive reticu- 
loendothelial system is primarily responsible for the abnormally rapid clearance 
of sensitized red cells. 
In order that the patients' rheumatoid factors had adequate opportunity to 
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FIG. 4. The survival in patients with rheumatoid arthritis of CrSt-labeled red cells sensi- 
tized with various anti-Rh sera. The shaded area represents the range of survival of similarly 
sensitized cells in normal individuals (Fig. 3). 
react with the injected,  sensitized red cells, these cells on two occasions were 
incubated in vitro with undiluted rheumatoid serum for 1 hour and thereafter 
infused into the rheumatoid serum donor. At the completion of the incubation 
period there was some rouleaux formation but little agglutination. The kinetics 
of red cell sequestration were not accelerated by this preincubation procedure. 
B.  Heterologous  A ntiglobulins. I 
The effect of an immune antiglobulin  on  the  destruction  of Rh-sensitized 
red cells was studied  in 2  normal subjects  and in 1 patient with rheumatoid MANUEL  E.  KAPLAN  AND  JAMES  H.  JANDL  117 
arthritis.  Each of these subjects had been injected previously with sensitized 
red cells and had sequestered them normally. When such Cr51-1abeled sensitized 
red cells were admixed with 10 volumes of immunologically inert red cells and 
then incubated with sterile rabbit antiserum, approximately 10 per cent of the 
cells  were agglutinated--an  appropriate  fraction  considering  the dilution  of 
sensitized with non-sensitized red cells. Mter infusion,  the sensitized  cells dis- 
appeared  from  the  circulation  very promptly  (Table VII,  Fig.  5).  Hepatic 
Cr  51 uptake was prominent in 2 of the 3 cases; in the third subject progressively 
increasing  precordial Cr ~1 activity suggested possible sequestration of some of 
the agglutinates in the pulmonary vascular bed. 
DISCUSSION 
The available evidence suggests that rheumatoid factors are antibodies re- 
active  with  7S  "y-globulins.  The  manifest  ability  of  these  macroglobulins: 
TABLE VII 
The Effect of Incubation  with Rabbit Antiglobulin  Serum on the Survival and 
Sequestration of Rh-Sensitized  Red Cells 
Subject 
Bay. 
O'Mal. 
COl*. 
Anti-Rh  Cr  la-survival 
t ~, mln. 
Ges.  6 
~  3 
"  5.5 
c.p.m, 
Spleen/liver 
1.5 
0.5 
1.6 
(a)  to agglutinate particles  (22)  or red cells  (23) coated with  7S T-globulin; 
(b)  to precipitate aggregated T-globulin  (6)  and  to enhance its phagocytosis 
in vitro (24); and (c) to form 22S complexes with native, 7S 3,-globulins in vivo 
(1, 2), demonstrates conclusively that the rheumatoid factors do interact with 
T-globulin, although it does not indicate whether this interaction is immunologic 
in  nature.  Agglutination  (25,  26)  and  opsonization  (25-27)  are not specific 
indications  for an  immune reaction,  and  it is  evident  that  specific protein- 
protein interactions, as between hemoglobin and haptoglobin (28), and specific 
protein-cell interactions,  as between transferrin  and immature red cells  (29), 
may represent non-immunologic events. The real bases for the belief that rheu- 
matoid factors are antibodies are that they possess the physico-chemical and 
antigenic properties of antibodies and  that  they manifest specificity in  their 
reactions with various  7S "pglobulins.  In seeming  conflict  with  this  concept 
was the finding by Grubb (30) that the parenteral administration of Gin (a+) 
T-globulin  to rheumatoid patients whose sera manifested anti-Gin (a) activity 
in vitro resulted in no systemic or local anaphylactoid reactions and no detect- 
able diminution  in  the half-life  of the administered T-globulin.  Accordingly, 
Grubb  (31)  conceives  of rheumatoid  factor  as  a  "heavy weight brother  of 118  IMMUNE  HEMOLYSIS  IN  VIVO 
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complement" and  has pondered  the  question "... whether  the  addition of 
these  macrogtobullns.., to... 7S  antibodies might alter  some  function or 
manifestation  of the 7S antibody". The present studies were designed to demon- 
strate whether rheumatoid factors can indeed modify antibody activity in ~ivo 
and, if so, to compare their effects with those of classical antiglobulin antibodies. 
Initial experiments  in the rat established  that the interaction of immune 
rat anti-rabbit globulin with homologous red cells sensitized with incomplete 
rabbit antibody markedly accelerated the sequestration of the sensitized cells, 
primarily within the liver. It could be shown that quantities of coating rabbit 
antibody that alone were insufficient to provoke red cell sequestration in dvo, 
did so after addition of immune antiglobulin (Fig.  1 B). Analogous studies in 
man demonstrated that immune rabbit anti-globulin hastened the destruction of 
R_h-positive red cells coated with incomplete Rh antibody. Both in man and in 
the rat the intensity of red cell sequestration induced by immune antiglobulins 
directly paralleled  their agglutinating activity with respect  to the sensitized 
cells. 
In contrast, the sequestration of sensitized red cells in patients with rheu- 
matoid arthritis was not accelerated,  except in a single patient with "hyper- 
splenism," although serum for each was capable of agglutinating the sensitized 
cells in vitro. The absence of significant red cell agglutination when sensitized 
cells were mixed with undiluted rheumatoid serum (a prozone  phenomenon) 
seemed the most likely explanation of this finding. In an attempt to circumvent 
the prozone, sensitized cells were agglutinated in vitro with dilute rheumatoid 
serum (Cor.) prior to their infusion. Despite this maneuver, the rate of destruc- 
tion of these cells after their injection into the rheumatoid patient was not 
accelerated (Fig. 6). Presumably the agglutinates immediately  dispersed in dvo 
much as they do in vitro in undiluted rheumatoid serum. 
As previously stated, despite intensive efforts to locate a single rheumatoid 
serum  that,  when  undiluted,  strongly agglutinated Rh-sensitized  red  cells, 
we were unable to do so. Others  have reported that such rheumatoid sera do 
exist (32-34)  and that prozones,  when found, may be ascribed  to the simul- 
taneous occurrence in the rheumatoid serum of an anti-Gin (a, b, or x) rheuma- 
toid  factor  and  the  corresponding  Gin-type of gamma globulins  (32, 35). 
However, we do not believe that such reasoning can satisfactorily explain the 
prozones  herein described.  Harboe (34) has reported that red cells sensitized 
with either  "Ripley" or  "Murphy" are strongly agglutinated by nearly all 
rheumatoid sera and that "prozones are rare." It is ditficult to believe that all 
35  of our randomly selected  rheumatoid sera  would,  on the basis  of chance 
alone,  agglutinate Ripley- or Murphy-sensitized red cells with the formation 
of prozones. Rather we suggest that this discrepancy may arise from differences 
in methodology. In the present studies (a)  tltrations were begun with whole 
serum; (b) care was taken to distinguish between the effect on sensitized cells 120  HEMOLYSIS IN  VIVO 
of rouleaux-forming globulins  zz and that of true agglufinins; and  (c)  observa- 
tions were made on unspun  suspensions incubated no longer than 2  hours.  It 
is probable that procedures such as centrifugation or overnight  storage of cell 
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Fzo. 6. The survival in patient Cor. of CrSZ-labeled  Rh-sensitized  red cells agglutinated, 
before injection, by dilute Cor. serum. 
suspensions in the cold may yield different results that of necessity would bear 
less strongly on in dvo mechanisms. It is possible, of  course, that rheumatoid 
patlents do exist whose whole serum agglutinates  R_h-sensitized red cells both 
in vitro  and in ~o.  Whether, in such individuals, significant alteration  in the 
kinetics would occur is open to speculation. MoUison (37) noted an abnormally 
n It should be noted whenever titering sera (including rheumatoid sera) that contain ele- 
vated concentrations of T-globulin, that the first one or two dilutions may contain suffident 
globulin levels to agglutinate sensitized cells non-specifically through the induction of rouleaux 
formation (36). Accordingly, the existence of a prozone may be more readily seen in serum 
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rapid disappearance of Rh-sensitized red cells in one patient  with severe rheu- 
matoid  arthritis.  Serum  from  this  patient  agglutinated  the  sensitized  cells 
in  vitro,  and this activity was attributed  to the  presence of "Grubb type of 
agglutinating factor." However, there is no information on the size of the pa- 
tient's spleen, the primary site of sequstration of the sensitized  red cells or the 
effect of the patient's undiluted serum on the sensitized cells. 
In  order to explore  the interaction  of rheumatoid  factor with incomplete 
coating antibody in the prozone region,  a variety of in ~iIro studies were per- 
formed. As previously reported by Grubb (30) it was found that simple dilution 
with saline  of a  prozone system produced prompt red cell agglutination.  An 
analogous volume effect in the F-II precipitin reaction  has been observed by 
Vaughan and others (38). This latter phenomenon was attributed by Christian 
(39) and by Vaughan (40) to an inhibitory effect of the 7S "g-globulin present. 
The induction of agglutination by the simple addition of saline indicates that 
it is the relative concentration, rather than the absolute quantity, of -y-globulin 
present that must determine the degree of inhibition produced. If, as has been 
shown by others (39, 41), the reactivity of rheumatoid macroglobulin with 7S 
~/-globulin is related  to  the degree of aggregation  of the T-globulin  (i.e.  the 
concentration or density of "t-globulin molecules at a given locus) a theory may 
be constructed to explain the observed volume effects. Free T-globulin molecules 
ha the plasma and those sterically fixed or aggregated by physical (e.g. heating) 
or immunological means may compete for combining  sites on the rheumatoid 
macroglobulin. In an undiluted system, free T-globulin  is present in relatively 
high concentration  and can compete successfully for rheumatoid factor. The 
latter is, thereby, prevented from reacting extensively with the lesser amounts of 
aggregated or cell-fixed "y-globulin and suboptimal precipitation or agglutina- 
tion  results.  In more  dilute  systems the concentration  of free "y-globulin is 
diminished;  however, no concomitant  reduction in  the  concentration  of ag- 
gregated ~,-globulin or of the ~,-globulin fixed at the cell-medium interface can 
occur. The interaction of rheumatoid macroglobulin with the fixed qc-globulin 
is thereby favored and results in augmented precipitation or agglutination. 
Viewed in this context it is understandable why rheumatoid factors are not 
absorbed from undiluted  rheumatoid  serum by packed,  sensitized  red cells. 
The maximum quantity of specific antibody that can be affaxed immunologi- 
caUy to the surface of a  red cell is limited by the  availability  of  the  corre- 
sponding antigen (42). On the addition of undiluted rheumatoid serum to opti- 
mally sensitized cells,  the density of free ~-globulin may greatly exceed that 
of the  aggregated  antibody fixed  at  the cell-serum  interface.  Consequently, 
there  is  little  tendency  for rheumatoid  macroglobulin  to  interact  with  the 
sensitized cells. If, however, one attempts to elute rheumatoid factor from such 
cells,  they must first be washed in saline.  The addition of saline  necessarily 
dilutes the free "y-globulin present. The "y-globulin density at the cell surface 122  IMMUNE  HEMOLYSIS  IN  VIVO 
may then rival that of the medium, favoring union with rheumatoid factor and, 
thereby,  cell agglutination.  Spuriously large  quantities  of rheumatoid  factor 
activity may then  be eluted from the washed cells  by standard  techniques. 
Such a phenomenon may account for the results of many reported absorption 
studies  (43,  44). 
The interpretation offered above does not conflict with the view that rheu- 
matoid factors are antibodies directed against 3"-globulin. The results are also 
compatible with the concept that rheumatoid factors are weakly reactive with 
all unaltered T-globulin  (9) and more strongly reactive with buried antigenic 
determinants  in  the T-globulin  molecule that  are exposed during  molecular 
fixation  or aggregation. 
Whatever  the nature  of the bonds between rheumatoid factors and  unde- 
natured 3"-globulins, it is apparent  that  they are extraordinarily labile or,  at 
least, readily reversible.  That this is so is indicated by the fact that sensitized 
red cells that have been agglutinated by dilute rheumatoid serum, are immedi- 
ately disagglufinated when the same serum is added  thereafter  in undiluted 
form. Accordingly,  it is possible that the stability of the bonding is critically 
dependent on the number of combining sites involved and that only when the 
local concentration of reacting T-globulin  sites is sufficiently great to permit 
multiple  interactions  with  each  macroglobulin  molecule  does  agglutination 
occur. Thus, an anti-Rh T-globulin such as that of Ripley that possesses multi- 
ple Gm groups would, and does, react more strongly than an ordinary anti-Rh 
globulin.  An anti-Rh sera such as Murphy, containing antibodies to more than 
one factor at the Rh locus could create a clustering of 3"-globulins at the cell 
surface that would favor multiple reactions with a rheumatoid factor. Finally, 
aggregated T-globulin  would have a  marked advantage by virtue of its high 
density of fixed 3"-globulin sites,  and indeed, aggregated 3,-globulin is actually 
precipitable by whole, undiluted rheumatoid serum in vitro (1, 39, 41). 
Whatever hypothesis is advanced, the present studies indicate that in the 
usual patient with rheumatoid arthritis  there exists  a  combination of factors 
that  effectively prevents  the  interaction  of rheumatoid  macroglobulin  with 
incomplete Rh antibodies, whether or not there exists demonstrable Gm "in- 
compatibility." The possibility must be recognized  that  other,  more highly 
aggregated,  antigen-antibody  complexes  may react  in  ~ivo with  rheumatoid 
macroglobulins  much  more  efficiently,  and,  perhaps  with  pathologic  conse- 
quence (41).  To date there have been no reported studies in vivo bearing on 
this concept. 
If  rheumatoid  macroglobulins  are  indeed  capable  of  effecting  pathologic 
damage in vivo, the latter  should logically  first become manifest in a  hypo- 
gammaglobulinemic  environment.  It  is  significant  that  rheumatoid  arthritis 
is primarily a disease of synovial membranes  (45).  Synovial fluids being nor- 
mally hypoproteinemic  (46)  may,  as  a  consequence,  be a  perfect milieu  to MANUEL E.  KAPLAN AND ~'AMES H.  JANDL  123 
activate the postulated deleterious properties  of rheumatoid factors. In this 
context the hypergammaglobulinemia that commonly occurs in rheumatoid 
patients may be considered as "protective." Admittedly these hypotheses are 
highly conjectural; however, they are of sufficient theoretic interest to merit 
further investigation. 
SUM~LRY 
Studies were undertaken in man and in the rat comparing the effects of rheu- 
matoid factors and immune antiglobulins on red cells sensitized with incomplete 
antibodies. 
The interaction of immune antiglobulins with sensitized red cells produced 
(a) agglutination in vitro and (b) an accelerated sequestration of the sensitized 
cells  in  dvo.  In  contrast,  rheumatoid  macroglobulins,  although  capable  of 
agglutinating R_h-sensitized red cells in vitro, did not modify their destruction 
in vivo. The failure of rheumatoid factors to function as antiglobulins in dvo 
appears to reflect their non-reactivity with sensitized cells in whole serum. 
It is suggested: (a) that the native (7S) gamma globulins of plasma competi- 
tively inhibit rheumatoid factors from reacting with fixed antibody in the blood 
stream; (b) that if these macroglobulins do indeed have pathogenetic activity, 
this may be limited to body fluids of low protein content. 
The technical assistance of Laurie T. Dancy is gmtefuUy  acknowledged. 
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